Help us: Donate
Follow us on:
×

Menu

Back

Category: Press Releases

Researchers from the University of Connecticut, Stanford University, Université Laval Quebec, and NSU Florida have helped test large-scale exogenous mitochondrial transplants in animal disease models and in-vitro human cells. The results suggest broad efficacy for targeting the immune system, brain, retina, liver, skin, and systemic anti-aging. This is the first time that a mitochondrial transplant...
Rejuveron Press Release
Rejuveron Life Sciences AG (‘Rejuveron’), a Zürich-based biotechnology company developing therapies to promote healthy aging, is pleased to announce that the first participant has been treated in Endogena Therapeutics’ phase 1/2a clinical study of its lead product, EA-2353, a photoreceptor regeneration treatment for retinitis pigmentosa (RP). See Endogena’s full press release here. Rejuveron has a near-majority...
Switzerland, Jun 30, 2022 - Molecule, a comprehensive funding and incubation ecosystem for early-stage biopharma research, announced this week they raised $12.7 million in seed funding. The round was led by Northpond Ventures with participation from Shine Capital, 1kx, Fifty Years, KdT Ventures, BACKED VC, Inflection VC, Chris Leiter, Balaji Srinivasan, Zee Prime Capital, The...
Rejuvenation Startup Summit
Berlin/Germany, June 23, 2022 - The Rejuvenation Startup Summit (Berlin, Oct. 14-15, 2022) is a vibrant networking event that brings together startups and members of the longevity venture capital/investor ecosystem – all aiming to create therapies to vastly extend the healthy human lifespan. Rejuvenation/Longevity biotech is a new, emerging field of medicine. It aims to prevent and reverse...
The NOVOS company logo in orange
NEW YORK - June 15, 2022 - NOVOS, a company that develops science-based products to slow down aging, announced results of two studies demonstrating that the combination of ingredients in its products, NOVOS Core and NOVOS Boost, protect against DNA damage and cellular aging (senescence). A study found that a combination of the 12 ingredients...
Longevity Investors Conference
This leading investors-only conference in the longevity field will bring together the world's most renowned longevity experts and private and institutional investors in the heart of the Swiss Alps. Zug, June 14, 2022 - Longevity Investors Conference (LIC) has the honour of welcoming leading longevity experts and scientists such as George Church (Professor of Genetics, Harvard...